Effects of hemolysis, bilirubin, and lipemia interference on coagulation tests detected by two analytical systems. (17th December 2019)

• Record Type: Journal Article
• Authors: Nougier, Christophe; Jousselme, Emilie; Sobas, Frédéric; Pousseur, Valentin; Négrier, Claude
• Is Part Of: International journal of laboratory hematology. Volume 42:Number 1(2020:Feb.)
• Page Start: 88
• Page End: 94
• Publication Date: 2019-12-17
• Subjects: coagulation -- hemolysis -- icterus -- interference -- lipemia; Hematology -- Periodicals; Blood -- Diseases -- Periodicals; Hematology -- Periodicals; 616.15005
• DOI: 10.1111/ijlh.13147
• Languages: English
• ISSNs: 1751-5521

Abstract

Abstract: Introduction: Interference on biological assays due to hemolysis, icterus, or lipemia (HIL) could represent a significant source of analytical errors leading to inaccurate interpretation of results. The aim of this study was to assess the HIL interference on prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen, using mechanical and optical detection methods. Methods: Control plasmas and plasmas from patients treated with vitamin K antagonists or unfractionated heparin, with or without HIL, were performed on two analytical detection systems in order to identify potential analytical biases. Whether HIL lead to significant biological interferences was also evaluated, and a cutoff point for HIL‐induced analytical bias was determined. Results: Hemolysis influenced PT and aPTT when hemoglobin was at 5 and 1.5 g/L in plasma, respectively. At 1.8 g/L, a positive relationship was found between the bias and the hemoglobin supernatant level only for fibrinogen measurement, using optical detection. For icteric interference, no significant bias was observed until a bilirubin concentration of 30 mg/dL. Lipamia (>500 mg/dL) led to analytical interference when using the optical analyzer. Conclusion: The present study detected analytical interferences such as lipemia (>500 mg/dL) on coagulation tests on the optical analyzer. We also found a biological impact on the results in case of hemolyzed sample: Fibrinogen was decreased when the hemoglobin level was superior to 1.8 g/L, PT was prolonged beyond 5 g/L, and aPTT was shortened beyond 1.5 g/L hemoglobin concentration, especially in patients treated with heparin. Above these thresholds, it is important not to give results that could influence the clinical decision.